Citation Impact
Citing Papers
Resection of Non–Small Cell Lung Cancers Reverses Tumor-Induced Gene Expression Changes in the Peripheral Immune System
2011
Gallic Acid Suppresses Lipopolysaccharide-Induced Nuclear Factor-κB Signaling by Preventing RelA Acetylation in A549 Lung Cancer Cells
2009
Modulators of Arginine Metabolism Do Not Impact on Peripheral T-Cell Tolerance and Disease Progression in a Model of Spontaneous Prostate Cancer
2011
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen
2013
DNA methylation arrays as surrogate measures of cell mixture distribution
2012 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Targeting VEGF signalling via the neuropilin co-receptor
2012
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
2022 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Silymarin and its constituents in cardiac preconditioning
2014
Silibinin modulates TNF‐α and IFN‐γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells
2011
Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases
2019
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Depletion of Tumor-Associated Macrophages Slows the Growth of Chemically Induced Mouse Lung Adenocarcinomas
2014
Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
2014
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Silibinin inhibits human nonsmall cell lung cancer cell growth through cell‐cycle arrest by modulating expression and function of key cell‐cycle regulators
2009
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Preventive effect of silymarin in cerebral ischemia–reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation
2010
Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells
2014
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Anti-Cancer Efficacy of Silybin Derivatives - A Structure-Activity Relationship
2013
In vitro antitumor activity of silybin nanosuspension in PC-3 cells
2011
Emerging Biological Principles of Metastasis
2017 Standout
Silibinin attenuates oxidative metabolism and cytokine production by monocytes from preeclamptic women
2013
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
2013
Multitargeted therapy of cancer by silymarin
2008 Standout
A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice
2011 StandoutNobel
Targeting silibinin in the antiproliferative pathway
2010
Effect of Silibinin in Reducing Inflammatory Pathways in In Vitro and In Vivo Models of Infection-Induced Preterm Birth
2014
Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer
2013
Proanthocyanidins: A comprehensive review
2019
Macrophage M1/M2 polarization
2020 Standout
Neutrophils in cancer: neutral no more
2016 Standout
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Survivin: A new target for anti-cancer therapy
2009
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Silybin and the liver: From basic research to clinical practice
2011
Choline intake and risk of lethal prostate cancer: incidence and survival
2012
Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation
2014
Silibinin inhibits expression of HIF-1α through suppression of protein translation in prostate cancer cells
2009
The Protective Effect of Silibinin Against Mitomycin C–Induced Intrinsic Apoptosis in Human Melanoma A375-S2 Cells
2009
Silybin-Mediated Inhibition of Notch Signaling Exerts Antitumor Activity in Human Hepatocellular Carcinoma Cells
2013
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Grape seed extract inhibits VEGF expression via reducing HIF-1 protein expression
2009
Young-onset colorectal cancer
2023
Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
2009
Redox Control of Inflammation in Macrophages
2013
Regulation of NF-E2-Related Factor 2 Signaling for Cancer Chemoprevention: Antioxidant Coupled with Antiinflammatory
2010
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
2015 Standout
Exosomes
2019 Standout
Human prostasomes express glycolytic enzymes with capacity for ATP production
2013
Macrophage Polarization
2016 Standout
The Therapeutic Potential of Apigenin
2019 Standout
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
The role of the hypoxia‐Nrp‐1 axis in the activation of M2‐like tumor‐associated macrophages in the tumor microenvironment of cervical cancer
2018
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Wound Healing: A Cellular Perspective
2018 Standout
Meat consumption, health, and the environment
2018 StandoutScience
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
FLAVONOIDS NUTRACEUTICALS IN PREVENTION AND TREATMENT OF CANCER: A REVIEW
2018
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
New Therapeutic Potentials of Milk Thistle (Silybum marianum)
2013
Potential health hazards of eating red meat
2016
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Flavonolignans from Aspergillus iizukae, a Fungal Endophyte of Milk Thistle (Silybum marianum)
2014
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of Komal Raina being referenced
Dietary Feeding of Silibinin Inhibits Prostate Tumor Growth and Progression in Transgenic Adenocarcinoma of the Mouse Prostate Model
2007
Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3
2009
Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice
2008
Tumor Progression Stage and Anatomical Site Regulate Tumor-Associated Macrophage and Bone Marrow-Derived Monocyte Polarization
2010
Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells
2013
Energy deprivation by silibinin in colorectal cancer cells
2013
Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: Comparison with silymarin and silibinin
2008
Chemopreventive and Anti-Cancer Efficacy of Silibinin Against Growth and Progression of Lung Cancer
2013
Role of oxidative stress in cytotoxicity of grape seed extract in human bladder cancer cells
2013
Effect of silibinin in human colorectal cancer cells: Targeting the activation of NF‐κB signaling
2011
Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells
2009
Identifying Molecular Targets of Lifestyle Modifications in Colon Cancer Prevention
2013
Angiopreventive Efficacy of Pure Flavonolignans from Milk Thistle Extract against Prostate Cancer: Targeting VEGF-VEGFR Signaling
2012
Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells
2012
Combinatorial strategies for cancer eradication by silibinin and cytotoxic agents: efficacy and mechanisms
2007
Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals
2014
Stage-Specific Inhibitory Effects and Associated Mechanisms of Silibinin on Tumor Progression and Metastasis in Transgenic Adenocarcinoma of the Mouse Prostate Model
2008
Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target
2009
Silibinin Suppresses Growth of Human Prostate Carcinoma PC-3 Orthotopic Xenograft via Activation of Extracellular Signal-Regulated Kinase 1/2 and Inhibition of Signal Transducers and Activators of Transcription Signaling
2009
Silibinin Feeding Alters the Metabolic Profile in TRAMP Prostatic Tumors: 1H-NMRS–Based Metabolomics Study
2009
Oral Grape Seed Extract Inhibits Prostate Tumor Growth and Progression in TRAMP Mice
2007
Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine–induced urinary bladder carcinogenesis in male ICR mice
2007
Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice
2008
Silibinin Prevents Lung Tumorigenesis in Wild-Type but not in iNOS−/− Mice: Potential of Real-Time Micro-CT in Lung Cancer Chemoprevention Studies
2010